Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

MARKER GENE REMOVED FROM ALTERED PLANTS

Dec. 4, 1991

FIELD STUDY GUIDELINES DUE

Dec. 4, 1991

IVAX RAISES $110.5 MILLION IN PRIVATE OFFERING

Dec. 4, 1991

GENSIA SUBSIDIARY GETS TWO ANDAs

Dec. 4, 1991

ITALY APPROVES BTGC's GROWTH HORMONE

Dec. 4, 1991

CAL BIO TO TAKE $6 MILLION CHARGE

Dec. 4, 1991

GENENTECH LICENSES CAMBRIDGE'S HIV PROTEIN

Dec. 4, 1991

MEDIMMUNE, MERCK COMPLETE DEAL

Dec. 4, 1991

BLOCKED RICIN TARGETS CANCER

Dec. 4, 1991

CIBA SUES TO SNUFF ALZA'S NICOTINE PATCH

Dec. 3, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...